Edwards Lifesciences (NYSE: EW) lists vested RSUs and prior 22,430-share sale

Rhea-AI Filing Summary

Edwards Lifesciences Corporation submitted a Form 144 notice reporting proposed sales tied to recent equity-compensation vesting events. The filing lists restricted stock lapses on 05/03/2026 (523 shares), 05/07/2026 (4,222 shares), 05/08/2026 (5,489 shares) and a PSU/RSU entry on 05/11/2026 (26,640 shares). The filing also records a prior sale of 22,430 shares for $1,719,742.00 on 02/12/2026.

Key Figures

Prior sale: 22,430 shares Proceeds from prior sale: $1,719,742.00 Restricted stock lapse: 523 shares +3 more

6 metrics

Prior sale 22,430 shares sold on 02/12/2026

Proceeds from prior sale $1,719,742.00 proceeds reported for 02/12/2026 sale

Restricted stock lapse 523 shares Restricted Stock Lapse on 05/03/2026

Restricted stock lapse 4,222 shares Restricted Stock Lapse on 05/07/2026

Restricted stock lapse 5,489 shares Restricted Stock Lapse on 05/08/2026

PSU/RSU entry 26,640 shares PSU / RSU listed on 05/11/2026

Key Terms

Restricted Stock Lapse, PSU / RSU, Form 144

3 terms

Restricted Stock Lapse regulatory

"Restricted Stock Lapse | EDWARDS LIFESCIENCES CORPORATION | 523 | 05/03/2026"

PSU / RSU financial

"05/11/2026 | PSU / RSU | EDWARDS LIFESCIENCES CORPORATION | 26640"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	36874	2873775.00	575800000	05/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/03/2026	Restricted Stock Lapse	EDWARDS LIFESCIENCES CORPORATION			523	05/03/2026	Equity Compensation
Common	05/07/2026	Restricted Stock Lapse	EDWARDS LIFESCIENCES CORPORATION			4222	05/07/2026	Equity Compensation
Common	05/08/2026	Restricted Stock Lapse	EDWARDS LIFESCIENCES CORPORATION			5489	05/08/2026	Equity Compensation
Common	05/11/2026	PSU / RSU	EDWARDS LIFESCIENCES CORPORATION			26640	05/11/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bernard J Zovighian ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	02/12/2026	22430	1719742.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)